IMVT: Immunovant, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 2,520.73
Enterprise Value ($M) 2,146.05
Book Value ($M) 352.62
Book Value / Share 2.08
Price / Book 7.15
NCAV ($M) 344.23
NCAV / Share 2.03
Price / NCAV 7.32

Profitability (mra)
Return on Invested Capital (ROIC) -1.09
Return on Assets (ROA) -0.57
Return on Equity (ROE) -0.62

Liquidity (mrq)
Quick Ratio 6.04
Current Ratio 6.04

Balance Sheet (mrq) ($M)
Current Assets 412.54
Assets 420.93
Liabilities 68.31
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Non Redeemable Common Stock Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-26 13G Deep Track Capital, LP 5.59 850.00
03-07 13G/A Fmr Llc 10.10 36.22
01-15 13D/A Roivant Sciences Ltd. 56.90 21.10

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 219,096 661,998 33.10
2025-04-16 311,018 1,295,602 24.01
2025-04-15 306,515 973,453 31.49
2025-04-14 320,690 957,973 33.48

(click for more detail)

Similar Companies
IFRX – InflaRx N.V. IGMS – IGM Biosciences, Inc.
IMUX – Immunic, Inc. INBX – Inhibrx Biosciences, Inc.
INDV – Indivior PLC


Financial data and stock pages provided by
Fintel.io